Meeting description: We updated the Member on Voluntary Scheme for Branded Medicines Pricing and Access (VPAS) VPAS and explained the consequence of not having a Voluntary Scheme and the impact it would have for pharma companies launching new medicines in the UK.
Topic label: Health